Sanofi manufactures Suliqua solostar, which is an anti-diabetic drug. Soliqua solostar is a mixture of insulin glargine, long-acting insulin, and lixisenatide, a glucagon-like peptide-1 receptor agonist.
Soliqua Solostar Dosage form
1. Soliqua (100/33 units)
In a 3-mL Solostar pen, Soliqua 100/33 includes 100 units of insulin glargine and 33 mg of Lixisenatide.
2. Soliqua 100/50:
In a 3mL Solostar pen, Soliqua 100/50 has 100 units of insulin glargine and 50 mg of Lixisenatide.
Soliqua Solostar Uses:
Soliqua Solostar insulin injection is a great option to use in conjunction with exercise and diet to help improve the control of glycemic levels in those who have Type 2 Diabetes. An injection generally administers Soliqua under the skin.
Soliqua insulin can’t be given intramuscularly, intravenously, or through an insulin pump.
Soliqua Injections that are cold should not be used; instead, let them be normal to room temperature before use. Soliqua is an excellent choice to regularly inject through the abdominal region, the hip, or the upper arm. You should rotate the injection site every time you take soliqua to prevent lipodystrophy or localized skin amyloidosis.
Dose of Soliqua at least an hour before your breakfast. It is best to do this at the same time every day. Soliqua solution should not be colored & it should be transparent.
In addition, you should not utilize it if you see particles or coloration.
Mixing or diluting the soliqua medicine with any other insulin solution or medication is not advised.
Typical Dose Range
Soliqua solostar is usually consumed in daily doses that range between 15 and 60 units. The recommended daily dose for soliqua is 60 units.
Each week increase the Soliqua dose up to 2-4 insulin units per week until you reach the proper plasma glucose balance in the fasting phase is achieved.
What if you missed Soliqua solostar dose.
If you miss a dose, skip to the next dose in the schedule. To make up for the missed dose, you should not take a doubled or increased dose.
Soliqua Solostar Storage/Stability
Before use, keep the pen pens in a refrigerator at 2degC to 8degC (36degF to 46degF). Pens should not be kept frozen. If it gets frozen, it must be thrown away.
Stay out of direct the sun.
Then, after the first time, you use The pen you can keep at room temperature at 25 degrees Celsius (77degF) and continue to use it.
Common side effects of Soliqua Solostar
- The body is tired,
- In pain,
- ear congestion,
- Loss of Voice
- muscle aches,
- Sore throat
- a runny or stuffy nose and
- warmth in the site of injection
- Skin discoloration
- the sensation of pressure
- It itches
- In pain,
- It stings.
Soliqua Solostar Serious Side effects
Soliqua could cause serious side effects, and seek medical assistance immediately if you experience some of the aforementioned signs. For example:
- Breathing difficulties
- The swelling of your cheeks, the lips, tongue, and neck
- abdomen or stomach pain
- Blurred vision,
- increased urination
- An irregular heartbeat
- flushed, dry skin,
- fruit-like breath odor,
- It itches
- increased thirst
- increased hunger
- cold sweats,
- clammy skin,
- mild headedness
- Loss of consciousness
- muscles cramps or pain,
- loss of appetite
- cool or pale skin,
- eyelids or even the skin that surrounds the eyes, faces, and lips,
- rapid weight gain,
- slurred speech,
- muscle twitching
- minimal or no urination,
- difficulty swallowing
- noisy breathing
- Numbness and trembling in the lips or feet,
- mild headedness
- abdomen pain that radiates into the back
- fast or weak heartbeat,
- dry mouth,
- compression in the chest.
- trouble breathing
- unproved weight loss,
- vulnerability and
- skin or eyes. Yellowing eyes or skin (jaundice)
- Hypersensitivity to insulin Glargine or lixisenatide as well as any one of the ingredients of the formulation.
- Soliqua is not recommended during episodes of hypoglycemia.
- By the Canadian labeling, patients suffer from multiple endocrine tumors type 2.
- Soliqua injection is not recommended during pregnancy or for nursing mothers.
- Soliqua is not recommended for patients who have an individual or family medical history of medullary thyroid cancer.